2610 related articles for article (PubMed ID: 18822897)
1. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E
Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
[TBL] [Abstract][Full Text] [Related]
2. Aminoglycoside resistant enterococcal endocarditis.
Eliopoulos GM
Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
[TBL] [Abstract][Full Text] [Related]
3. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
Wareham DW; Abbas H; Karcher AM; Das SS
J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
[TBL] [Abstract][Full Text] [Related]
4. [Aminoglycosides in the treatment of infectious endocarditis].
Malinverni R
Schweiz Med Wochenschr Suppl; 1996; 76():14S-20S. PubMed ID: 8677414
[TBL] [Abstract][Full Text] [Related]
5. Isolated pulmonic valve infective endocarditis: a persistent challenge.
Hamza N; Ortiz J; Bonomo RA
Infection; 2004 Jun; 32(3):170-5. PubMed ID: 15188078
[TBL] [Abstract][Full Text] [Related]
6. High-level aminoglycoside-resistant enterococcus causing endocarditis successfully treated with a combination of ampicillin, imipenem and vancomycin.
Antony SJ; Ladner J; Stratton CW; Raudales F; Dummer SJ
Scand J Infect Dis; 1997; 29(6):628-30. PubMed ID: 9571747
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
[TBL] [Abstract][Full Text] [Related]
8. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
[TBL] [Abstract][Full Text] [Related]
9. [A case report of an infective endocarditis caused by methicillin-resistant Staphylococcus aureus with successful mitral valve replacement].
Kawahira T; Wakita N; Nohara H; Shida T
Kyobu Geka; 1996 Jul; 49(8 Suppl):680-3. PubMed ID: 8741444
[TBL] [Abstract][Full Text] [Related]
10. Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: new insights and evidence from the literature.
Falcone M; Russo A; Venditti M
J Infect Chemother; 2015 May; 21(5):330-9. PubMed ID: 25813608
[TBL] [Abstract][Full Text] [Related]
11. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.
Miro JM; Cervera C; Garcia-de-la-Maria C; Del Rio A; Armero Y; Mestres CA; Grau JM; Marco F; Moreno A
Scand J Infect Dis; 2008; 40(11-12):968-72. PubMed ID: 18767002
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
Madrigal AG; Basuino L; Chambers HF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
[TBL] [Abstract][Full Text] [Related]
13. [Acquired data on the antibiotic treatment of bacterial endocarditis on native or prosthetic valves].
Hoen B; Leport C; Carbon C
Rev Prat; 1993 Oct; 43(16):2112-7. PubMed ID: 8134795
[TBL] [Abstract][Full Text] [Related]
14. Management of bacterial endocarditis.
Giessel BE; Koenig CJ; Blake RL
Am Fam Physician; 2000 Mar; 61(6):1725-32, 1739. PubMed ID: 10750879
[TBL] [Abstract][Full Text] [Related]
15. [Necrotising endocarditis of mitral valve due to Staphylococcus lugdunensis].
Celebi G; Büyükateş M; Doğan SM; Pişkin N; Aydemir H; Oztoprak N; Aktaş E; Bektaş S; Keskin A; Akduman D
Mikrobiyol Bul; 2009 Apr; 43(2):319-23. PubMed ID: 19621620
[TBL] [Abstract][Full Text] [Related]
16. Infective endocarditis caused by daptomycin-resistant Enterococcus faecalis: a case report.
Kanafani ZA; Federspiel JJ; Fowler VG
Scand J Infect Dis; 2007; 39(1):75-7. PubMed ID: 17366018
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
Lavoie SR; Wong ES; Coudron PE; Williams DS; Markowitz SM
Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374
[TBL] [Abstract][Full Text] [Related]
18. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.
Pericas JM; Cervera C; del Rio A; Moreno A; Garcia de la Maria C; Almela M; Falces C; Ninot S; Castañeda X; Armero Y; Soy D; Gatell JM; Marco F; Mestres CA; Miro JM;
Clin Microbiol Infect; 2014 Dec; 20(12):O1075-83. PubMed ID: 25040215
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with daptomycin: bacteraemia and endocarditis.
Levine DP
J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii35-39. PubMed ID: 18829724
[TBL] [Abstract][Full Text] [Related]
20. Nosocomial methicillin-resistant Staphylococcus aureus endocarditis with splenic abscess in a pregnant woman.
Ozkurt Z; Erkut B; Kadanali A; Ates A; Yekeler I
Jpn J Infect Dis; 2005 Oct; 58(5):323-5. PubMed ID: 16249631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
